Does Ketamine Work for Anxiety?

Ketamine for anxiety dose is a research question, not a do-it-yourself dosing decision. Small clinical studies suggest ketamine can reduce anxiety symptoms quickly for some people, especially when anxiety occurs alongside depression. But evidence for primary anxiety disorders remains limited, ketamine is not FDA-approved specifically for anxiety, and dose selection should be made by a qualified clinician who can assess risks, medications, and monitoring needs.

Research has examined several routes and dose levels, including subcutaneous ketamine at 0.5 and 1.0 mg/kg in a small study of generalized and social anxiety disorders. Those study doses do not establish a safe or appropriate dose for an individual patient.

What the evidence shows

Most evidence for ketamine's anxiety-related effects comes from depression trials. In these studies, anxiety scale scores often improved within hours or days of a single treatment alongside depressive symptoms. A systematic review published in Human Psychopharmacology concluded that the available clinical literature suggested potential anxiolytic effects, while also identifying the need for larger, better-controlled studies in diagnosed anxiety disorders.

According to the 2017 ascending-dose study by Glue and colleagues, 12 participants with treatment-resistant generalized anxiety disorder or social anxiety disorder received subcutaneous ketamine in an open-label phase, followed by randomized treatment, and anxiety improvements were reported at 0.5 and 1.0 mg/kg. The study was small, so its results are encouraging rather than definitive. Read the original study record on PubMed.

For people with generalized anxiety disorder, social anxiety disorder, panic symptoms, or other anxiety concerns, established treatments still matter. The National Institute of Mental Health describes anxiety disorders as conditions that can interfere with daily activities and notes that treatment commonly includes psychotherapy, medication, or both.

Why ketamine might affect anxiety

Ketamine is an NMDA receptor antagonist, meaning it changes signaling at a glutamate receptor involved in brain communication. Researchers are studying whether this effect, along with downstream changes in synaptic signaling and neuroplasticity, may influence circuits involved in fear, threat processing, and rumination.

These mechanisms are still being studied. They do not show that ketamine will treat a particular person's anxiety or replace a full clinical assessment. For a closer look at the research on brain adaptation, see neuroplasticity and ketamine and default mode network studies.

What dose research can and cannot tell you

A research dose is a protocol detail, not a prescription. Route of administration, body weight, health history, current medications, treatment setting, and the reason for treatment can all affect a clinician's decision. The 0.5 and 1.0 mg/kg doses reported by Glue and colleagues were used in one small subcutaneous study, not established as a standard for all anxiety patients.

Ask a treating clinician how they determine the starting dose, what changes would lead them to adjust or stop treatment, and what monitoring is used. If you are researching oral formulations, this guide to ketamine troche dosage explains why formulation-specific information matters. Treatment timing is also individualized, as discussed in how low-dose ketamine treatments may be spaced.

Who may benefit from a clinical conversation

A conversation may be reasonable for someone whose anxiety co-occurs with depression and who has not improved with standard care, provided a clinician can evaluate the full picture. It may be less appropriate for someone looking for an unsupervised dose, a guaranteed rapid fix, or a substitute for evaluation and ongoing mental health care.

The practical next step is to bring a clear symptom history, treatment history, medication list, and questions about safety to a qualified healthcare professional. If anxiety symptoms are severe, worsening, or include thoughts of self-harm, seek urgent local medical or crisis support.